Filing Details

Accession Number:
0001104659-11-065229
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-18 18:53:15
Reporting Period:
2011-11-16
Filing Date:
2011-11-18
Accepted Time:
2011-11-18 18:53:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1126234 Newlink Genetics Corp NLNK Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1512112 Stine Seed Farm, Inc. 22555 Laredo Trail
Adel IA 50003
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-16 838,095 $0.00 1,016,666 No 4 C Direct
Common Stock Acquisiton 2011-11-16 542,820 $0.00 1,559,486 No 4 C Direct
Common Stock Acquisiton 2011-11-16 814,231 $0.00 2,373,717 No 4 C Direct
Common Stock Acquisiton 2011-11-16 1,680,671 $0.00 4,054,388 No 4 C Direct
Common Stock Acquisiton 2011-11-16 2,142,857 $7.00 6,197,245 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2011-11-16 1,760,000 $0.00 1,760,000 $0.00
Common Stock Series C Preferred Stock Disposition 2011-11-16 1,000,000 $0.00 1,000,000 $0.00
Common Stock Series D Preferred Stock Disposition 2011-11-16 1,500,000 $0.00 1,500,000 $0.00
Common Stock Series E Preferred Stock Disposition 2011-11-16 320,000 $0.00 320,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Every one share of Series B Preferred Stock automatically converted into approximately 0.476 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  2. Every one share of Series C Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  3. Every one share of Series D Preferred Stock automatically converted into approximately 0.542 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  4. Every one share of Series E Preferred Stock automatically converted into approximately 5.252 shares of common stock upon the closing of the Issuer's initial public offering and had no expiration date.
  5. The shares were purchased in the Issuer's initial public offering.